Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$242,445
+$7,821 QoQ
Shares Held
1,547
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,230
of 1,603 holders
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $17,780,353 across 10 Drug Manufacturers - General names. NVS ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,947 | $4,050,059 | |
| 2 | LLY |
ELI LILLY & Co
|
3,245 | $3,892,150 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,037 | $2,703,254 | |
| 4 | ABBV |
AbbVie Inc.
|
9,282 | $2,335,722 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,874 | $1,752,841 | |
| 6 | AMGN |
Amgen Inc
|
3,488 | $1,263,074 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,974 | $747,561 | |
| 8 | PFE |
Pfizer Inc
|
21,776 | $524,366 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,445 | 1,547 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $234,624 | 1,536 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $211,906 | 1,537 | Shares | Sole | 2026-01-26 | |
| 2020-12-31 | $12,842 | 136 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||